DETECT Fentanyl and Xylazine Act of 2024

(1) in paragraph (13), by striking and at the end;

(2) in paragraph (14), by striking the period at the end and inserting; and; and

(3) by adding at the end the following:

(15) carrying out research, development, testing, evaluation, and cost-benefit analyses to improve the safety, effectiveness, and efficiency of equipment and reference libraries for use by Federal, State, local, and Tribal law enforcement agencies for the accurate detection of drugs or the disruption of drug trafficking for drugs such as fentanyl and xylazine, including, but not limited to—

(A) portable equipment that can detect and identify drugs with minimal or no handling of the sample;

(B) equipment that can separate complex mixtures containing low concentrations of drugs and high concentrations of cutting agents into their component parts to enable signature extraction for field identification and detection; and

(C) technologies that use machine learning or artificial intelligence (as defined in section 5002 of the National Artificial Intelligence Initiative Act of 2020 (15 U.S.C. 9401)) and other techniques to predict whether the substances in a sample are controlled substance analogues or other new psychoactive substances not yet included in available reference libraries.

(1) follow the recommendations, guidelines, and best practices described in the Artificial Intelligence Risk Management Framework (NIST AI 100–1) or any successor document published by the National Institute of Standards and Technology; and

(2) establish the Directorate of Science and Technology’s research, development, testing, evaluation, and cost-benefit analysis priorities under such section 302(15) based on the latest available information, including the latest State and Territory Report on Enduring and Emerging Threats published by the Drug Enforcement Administration or any successor document.

(1) in paragraph (13), by striking and at the end;

(2) in paragraph (14), by striking the period at the end and inserting; and; and

(3) by adding at the end the following:

(15) carrying out research, development, testing, evaluation, and cost-benefit analyses to improve the safety, effectiveness, and efficiency of equipment and the effectiveness and efficiency of reference libraries for use by Federal, State, local, Tribal, and territorial law enforcement agencies for the accurate detection of drugs, such as fentanyl and xylazine, including—

(A) portable equipment that can detect and identify drugs with minimal or no handling of the sample;

(B) equipment that can separate complex mixtures containing low concentrations of drugs and high concentrations of cutting agents into their component parts to enable signature extraction for field identification and detection; and

(C) technologies that use machine learning or artificial intelligence (as defined in section 5002 of the National Artificial Intelligence Initiative Act of 2020 (15 U.S.C. 9401)) and other techniques to predict whether the substances in a sample are controlled substance analogues or other new psychoactive substances not yet included in available reference libraries.

(1) follow the recommendations, guidelines, and best practices described in the Artificial Intelligence Risk Management Framework (NIST AI 100–1) or any successor document published by the National Institute of Standards and Technology; and

(2) establish the Directorate of Science and Technology’s research, development, testing, evaluation, and cost-benefit analysis priorities under such section 302(15) based on the latest available information, including specific drugs identified as threats in—

(A) the latest Homeland Threat Assessment published by the Department of Homeland Security;

(B) the latest State and Territory Report on Enduring and Emerging Threats published by the Drug Enforcement Administration; or

(C) any successor documents.

Not later than 7 days after the date of enactment of this Act, the Director of the United States Secret Service shall submit to the appropriate congressional committees a report that contains any and all information in the possession of the United States Secret Service relating to the failed assassination attempt on the life of Donald J. Trump in Butler, Pennsylvania, on July 13, 2024, including—

(1) the identity, motive, method, and actions of the shooter;

(2) requests for additional resources or protective measures for Donald J. Trump, his campaign, his organization, or any entity involved in preparing for the event;

(3) preparations for the event in Butler, Pennsylvania, by the United States Secret Service and other law enforcement entities;

(4) response by United States Secret Service to the shooter; and

(5) information on the ensuing investigation by the Federal Bureau of Investigation and any other investigating agency.

In this section, the term appropriate congressional committees means—

(1) the Committee on Homeland Security and Governmental Affairs and the Committee on the Judiciary of the Senate; and

(2) the Committee on Oversight and Accountability and the Committee on the Judiciary of the House of Representatives.